arrow
P

Pablo Hernáiz Driever

Charite—Universitätsmedizin Berlin and Freie Universität Berlin and Humboldt-Universität zu Berlin
H指数:47
被引数:9,992

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pediatric-Type Diffuse Low-Grade Gliomas with MYB Alterations: Neuroimaging of the Diffuse Astrocytomas, MYB- or MYBL1-Altered

儿科型弥漫性低级别胶质瘤的MYB改变:弥漫性星形细胞瘤的神经影像学,MYB或MYBL1改变

2025-11-012
PRE
Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registries

基于前瞻性试验E-HIT2000及后续登记研究的儿童颅内室管膜瘤高级风险分层模型开发

2025-09-300
PRE
A spatial map of MAPK-activated immunosuppressive myeloid populations in pediatric low-grade glioma

MAPK激活的免疫抑制性髓系细胞群在儿童低级别胶质瘤中的空间分布图

2025-09-150
PRE
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial (vol 30, pg 207, 2024)

复发/难治性小儿低度神经胶质瘤中的II型RAF抑制剂tovorafenib: 2期FIREFLY-1试验 (第30卷,207页,2024)

2025-04-160
OA
Constitutional variants in PTEN: a frequent finding in patients with papillary tumors of the pineal region subtype B (PTPR-B) associated with isolated loss of chromosome 10

PTEN基因的胚系变异:在伴有孤立性10号染色体丢失的松果体区乳头状肿瘤亚型B(PTPR-B)患者中是一种常见发现

2025-03-140
OA
MSH2, MSH6, MLH1, and PMS2 immunohistochemistry as highly sensitive screening method for DNA mismatch repair deficiency syndromes in pediatric high-grade glioma

MSH2、MSH6、MLH1和PMS2免疫组化作为儿科高级别胶质瘤中DNA错配修复缺陷综合征的高敏感性筛查方法

2025-02-020
OA
Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial

在FIREFLY-1试验中,托瓦雷芬尼(tovorafenib)这种II型RAF抑制剂对复发性/难治性视神经通路胶质瘤患儿的放射学和视觉反应。

2024-12-190
PRE
TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY (R/R) PEDIATRIC LOW-GRADE GLIOMA (PLGG): RESULTS FROM PATIENTS ON A DRUG HOLIDAY (DH) IN THE PHASE 2 FIREFLY-1 TRIAL
2024-11-110
PRE
HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN THE PHASE 2 FIREFLY-1 (PNOC026) TRIAL OF THE TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY (R/R) PEDIATRIC LOW-GRADE GLIOMA (PLGG)
2024-11-110
PRE
DNA methylation-array interlaboratory comparison trial demonstrates highly reproducible paediatric CNS tumour classification across 13 international centres

DNA甲基化阵列实验室间比较试验在13个国际中心展示了高度可重复的儿科CNS肿瘤分类

2024-10-160
OAAI
Medulloblastoma in children with Fanconi anemia: Association with FA-D1/FA-N, SHH type and poor survival independent of treatment strategies

范可尼贫血患儿的髓母细胞瘤: 与FA-D1/fa-n,SHH类型和不良生存无关的治疗策略的关联

2024-06-260
PRE
AGE ABOVE 12 MONTHS, ABSENCE OF SYNCHRONOUS, MULTIFOCAL DISEASE AND PATHOGENIC GERMLINE VARIANTS AT C-TERMINI ARE POSITIVE PROGNOSTIC FACTORS IN CHILDREN WITH RTPS1 (RHABDOID-TUMOR-PREDISPOSITION-SYNDROME)
2024-06-180
OAAI
TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY PEDIATRIC LOW-GRADE GLIOMA (PLGG): REVERSIBLE DECREASES IN GROWTH VELOCITY IN THE PHASE 2 FIREFLY-1 TRIAL

复发/难治性小儿低级别神经胶质瘤 (PLGG) 中的II型RAF抑制剂TOVORAFENIB: 2期FIREFLY-1试验中生长速度的可逆降低

2024-06-180
OAAI
MOLECULAR MARKERS AND PREDICTORS OF OUTCOME FOR PAEDIATRIC INTRACRANIAL EPENDYMOMA IN THE PROSPECTIVE, MULTICENTRE E-HIT2000 TRIAL AND SUBSEQUENT HIT-REGISTRIES: A POOLED ANALYSIS OF 244 PATIENTS

在前瞻性,多中心E-HIT2000试验和随后的HIT注册研究中,儿童颅内室管膜瘤的分子标志物和预后预测因素: 对244例患者的汇总分析

2024-06-180
OAAI
MALIGNANT TRANSFORMATION OF PEDIATRIC LOW-GRADE GLIOMA TO SECONDARY HIGH-GRADE GLIOMA - REPORT FROM THE GERMAN BRAIN TUMOR STUDIES
2024-06-180
OAAI
IMMUNOHISTOCHEMISTRY REPRESENTS A HIGHLY SENSITIVE SCREENING METHOD FOR MISMATCH REPAIR DEFICIENCY SYNDROMES IN PEDIATRIC HIGH-GRADE GLIOMA
2024-06-180
OAAI
MEDULLOBLASTOMA IN CHILDREN WITH FANCONI ANEMIA: ASSOCIATION WITH FA-D1/FA-N, SHH TYPE AND POOR SURVIVAL INDEPENDENT OF TREATMENT STRATEGIES

范可尼贫血患儿的髓母细胞瘤: 与FA-D1/fa-n,SHH类型和不良生存无关的治疗策略的关联

2024-06-180
OAAI